Steven D. Gore

Combined DNA Methyltransferase and Histone Deacetylase Inhibition in the Treatment of Myeloid Neoplasms

Steven D. Gore, Stephen B. Baylin, Elizabeth A. Sugar et al. · Cancer Research · 2006 · 472 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

MDS and secondary AML display unique patterns and abundance of aberrant DNA methylation

María E. Figueroa, Lucy Skrabanek, Yushan Li et al. · Blood · 2009 · 331 citations · Full text

Medicine, Molecular Biology, Oncology +14

Elevated Expression of the Apoptotic Regulator Mcl-1 at the Time of Leukemic Relapse

Scott H. Kaufmann, Judith E. Karp, Phyllis A. Svingen et al. · Blood · 1998 · 330 citations · Full text

Life Sciences, Cancer Biology, Oncology +16

Early epigenetic changes and DNA damage do not predict clinical response in an overlapping schedule of 5-azacytidine and entinostat in patients with myeloid malignancies

Tamer E. Fandy, James G. Herman, Patrick Kerns et al. · Blood · 2009 · 288 citations · Full text

Medicine, Molecular Biology, Oncology +16

Phase 1 and pharmacologic study of MS-275, a histone deacetylase inhibitor, in adults with refractory and relapsed acute leukemias

Ivana Gojo, Anchalee Jiemjit, Jane B. Trepel et al. · Blood · 2006 · 283 citations · Full text

Medicine, Oncology, Pharmacology +17